January 17, 2014
DAYTON — Julian G. Cambronero Ph.D., professor of biochemistry and molecular biology and Brage Golding Distinguished Professor of Research at the Wright State University Boonshoft School of Medicine, is chairing an international research conference sponsored by the Federation of American Societies for Experimental Biology (FASEB).
The conference, “Phospholipid Cell Signaling and Metabolism in Inflammation and Cancer,” will take place June 1-6, in Niagara Falls, N.Y. Cambronero is organizing the event along with George M. Carman Ph.D., Board of Governors professor of food science and director of the Rutgers Center for Lipid Research.
FASEB is the nation’s largest coalition of biomedical researchers and represents 27 scientific societies and more than 110,000 researchers worldwide. The nonprofit organization works to advance health and welfare by promoting progress and education in biological and biomedical sciences. FASEB sponsors a series of science research conferences annually, enabling experimental biologists to meet and explore new approaches to current research areas during the summer months.
The June 1-6 international conference will focus on the roles cell membrane phospholipids play in inflammation and cancer. Phospholipids are found in all living cells and are the structural basis of cell membranes. The conference will address the latest findings in how phospholipids can help in the treatment of inflammation and cancer.
The conference will include two keynote speakers, 32 invited plenary speakers, 16 junior scientists, two “meet the expert” sessions and four poster sessions. The speakers, who are from the United States, Canada, the United Kingdom, Spain, France, India, Mexico, Japan and South Korea among other countries, include National Academy of Sciences members, Howard Hughes Medical Institute investigators and journal editors.
For more information about the program, go to: https://secure.faseb.org/FASEB/meetings/summrconf/selectTopic.aspx?Sortfrom=2013. Click on the title, “Phospholipid Cell Signaling and Metabolism in Inflammation and Cancer.”